Results 131 to 140 of about 46,198 (239)

Effects of Hydroxyurea on Development and Regeneration

open access: yesNature, 1967
HYDROXYUKEA is a potent inhibitor of DNA synthesis and mitosis1–6. It is known that it interferes with the reduction of ribonucleotides to deoxyribonucleotides1–4. It is bacteriostatic for Escherichia coli7, where it induces a reversible inhibition of DNA synthesis without affecting the synthesis of RNA and proteins.
openaire   +3 more sources

Lost in the Vaso‐Occlusion: A Patient's Abdominal Pain Returns With a Vengeance

open access: yes
Pediatric Blood &Cancer, Volume 73, Issue 11, November 2026.
Dunia Hatabah   +5 more
wiley   +1 more source

The Effect of Polycythemia Vera on Pregnancy Complications. The Analysis of an American Population Database With Over 9 Million Deliveries

open access: yesEuropean Journal of Haematology, Volume 117, Issue 5, Page 1249-1257, November 2026.
ABSTRACT Objectives Polycythemia Vera (PV) is characterized by overproduction of erythrocytes, leading to a hypercoagulable state. Evidence regarding associations between PV and pregnancy outcomes is limited. The aim of our study was to provide robust evidence regarding the prevalence of pregnancy complications in women with PV.
Noah Margolese   +5 more
wiley   +1 more source

Feasibility and Safety of Venetoclax for Cytoreduction During Induction Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

open access: yesEuropean Journal of Haematology, Volume 117, Issue 5, Page 1258-1264, November 2026.
ABSTRACT Objective This study aimed to evaluate the feasibility and safety of venetoclax as a cytoreductive strategy during induction therapy in newly diagnosed acute promyelocytic leukemia (APL), and to provide an exploratory description of its early efficacy.
Yu Wang   +3 more
wiley   +1 more source

Hydroxyurea

open access: yesJournal of Biological Chemistry, 1967
Roger L.P. Adams, J.G. Lindsay
openaire   +1 more source

Hydroxyurea-induced melanonychia

open access: yesJAAD Case Reports, 2023
Michael G. Buontempo, BS   +6 more
openaire   +3 more sources

Beyond the CE Mark: A Call to Action for Minimum CGM Accuracy Standards in Central and Eastern European Nations

open access: yes
Diabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 9747-9752, November 2026.
Tomasz Klupa   +14 more
wiley   +1 more source

Hydroxyurea Use for Sickle Cell Disease Fact Sheet [PDF]

open access: yes
Hydroxyurea is an oral medicine that can help reduce sickle cell disease ...

core  

Current advances in 2025: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee

open access: yes
Transfusion, Volume 66, Issue 11, Page 2397-2409, November 2026.
Nabiha H. Saifee   +24 more
wiley   +1 more source

Home - About - Disclaimer - Privacy